drugset / Trial / NCT02362139

The Impact of Papaverine on First Stage of Labor

NCT02362139 ↗

Phase 3 Unknown 400 enrolled eran ashwal
RandomizedParallel-groupOpen-labelTreatment

Summary

In the investigators institution, there is a wide use of Papaverine in delivery room, but this use is optional, and is left to the discretion of the physician. The aim of the investigators study is to prospectively evaluate the influence of Papaverine administration in the latent phase of labor, on the duration of labor.

Timeline

Start
2015-02
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Papverine Unknown 80 mg Intramuscular

Indications

No indication recorded.